retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['breast']
$bctx briacell presents positive data demonstrating survival and clinical benefits in advanced metastatic breast cancer at the 2023 aacr 45 seconds delayed.
Democratizing insights.

Not investment advice.